國立高雄大學圖資館 |

Language: English

Back

Biopharmaceutical manufacturingprogress, trends and challenges /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Biopharmaceutical manufacturingedited by Ralf Portner.
Reminder of title:	progress, trends and challenges /
other author:	Portner, Ralf.
Published:	Cham :Springer International Publishing :2023.
Description:	ix, 495 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Pharmaceutical biotechnology.
Online resource:	https://doi.org/10.1007/978-3-031-45669-5
ISBN:	9783031456695$q(electronic bk.)

Biopharmaceutical manufacturingprogress, trends and challenges /
Biopharmaceutical manufacturingprogress, trends and challenges /[electronic resource] :edited by Ralf Portner. - Cham :Springer International Publishing :2023. - ix, 495 p. :ill., digital ;24 cm. - Cell engineering,v. 112542-9515 ;. - Cell engineering ;v.9..

Part I: Manufacturing of Recombinant Therapeutic Proteins -- Chapter 1. Single-Use Systems in Biopharmaceutical Manufacture: State of the Art and Recent Trends (Jossen et al.) -- Chapter 2. Recent Developments in Bioprocess Monitoring Systems (Rahmatnejad et al.) -- Chapter 3. Advances in Characterization of Industrial Bioreactors for Cell Culture Process (Fitschen et al.) -- Chapter 4. Continuous Bioprocessing for Upstream Process - Perfusion Process (Chotteau et al.) -- Chapter 5. Continuous Bioprocessing for Downstream (Gerstweiler) -- Chapter 6. Towards Digital Twin for Biopharmaceutical Processes: Concept and Progress (Ding et al.) -- Chapter 7. Integrated Process and Supply Chain Design and Optimization (Triantafyllou et al.) -- Chapter 8. Production of Complex Proteins in Plants - From Farming to Manufacturing (Nausch et al.) -- Chapter 9. Manufacturing of Recombinant Proteins Using Quality by Design (QbD) Methodology: Current Trend and Challenges (Shin and Landauer) -- Chapter 10. Biopharma 4.0 for Biologics Manufacturing Under Pandemic Constraints (Schmidt et al.) -- Chapter 11. Biopharma 4.0: Digital Technologies Driving Smart Manufacturing (Nargund et al.) -- Part II: Manufacturing Aspects of Cell and Gene Therapy -- Chapter 12. Essential Aspects of Mesenchymal Stem Cell Manufacturing (Fleischhammer et al.) -- Chapter 13. Towards a Continuous Production of Human Mesenchymal Stromal Cells in a Chemically Defined Medium: Opportunities and Challenges for a Robust and Scalable Expansion Process (Tasto and Salzig) -- Chapter 14. Biomanufacturing Aspects of Gene Therapy (Warnock) -- Chapter 15. Manufacturing and Quality of Advanced Therapeutics: Cellular Therapies, CAR-T and Gene Therapies (van den Bos et al.)

This volume "Cell Engineerring 11 - Biopharmaceutical Manufacturing: Progress, Trends and Challenges" is a source of the latest innovative research and technical development in biomanufacturing systems. It is organised into 2 parts: 1) Manufacturing of recombinant therapeutic proteins (e.g. therapeutic antibodies, biosimilars/biogenerics) and 2) Manufacturing aspects of cell and gene therapy. Each with selected chapters on the following topics for both up- and downstream, such as: Advanced process strategies, especially continuous manufacturing, Advanced culture techniques, especially single-use systems, Process transfer, scale-up/scale-down models, Processing advances/Manufacturing productivity/efficiency, Model-assisted process understanding and development/Digital Twins, Process controls and analytics, Quality control, Quality by design, Facility design and full-scale commercial systems, manufacturing technology innovation. The book comprises contributions of experts from academia and industry active in the field of cell culture development for the production of recombinant proteins, cell therapy and gene therapy, with consideration of Digital Twin's and facility design. The knowledge and expertise of the authors cover disciplines like cell biology, engineering, biotechnology and biomedical sciences. Inevitably, some omissions will occur in the test, but the authors have sought to avoid duplications by extensive cross-referencing to chapters in other volumes of this series and elsewhere. We hope the volume provides a useful compendium of techniques for scientists in industrial and research laboratories active in this field.

ISBN: 9783031456695$q(electronic bk.)

Standard No.: 10.1007/978-3-031-45669-5doiSubjects--Topical Terms:

189023
Pharmaceutical biotechnology.

LC Class. No.: RS380

Dewey Class. No.: 615.19

Biopharmaceutical manufacturingprogress, trends and challenges /
LDR:04438nmm a2200337 a 4500 001 654765
003 DE-He213
005 20240110103337.0
006 m d
007 cr nn 008maaau
008 240524s2023 sz s 0 eng d
020 $a 9783031456695$q(electronic bk.)
020 $a 9783031456688$q(paper)
024 7 $a 10.1007/978-3-031-45669-5 $2 doi
035 $a 978-3-031-45669-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RS380
072 7 $a PSF $2 bicssc
072 7 $a SCI049000 $2 bisacsh
072 7 $a PSF $2 thema
082 0 4 $a 615.19 $2 23
090 $a RS380 $b .B615 2023
245 0 0 $a Biopharmaceutical manufacturing $h [electronic resource] : $b progress, trends and challenges / $c edited by Ralf Portner.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a ix, 495 p. : $b ill., digital ; $c 24 cm.
490 1 $a Cell engineering, $x 2542-9515 ; $v v. 11
505 0 $a Part I: Manufacturing of Recombinant Therapeutic Proteins -- Chapter 1. Single-Use Systems in Biopharmaceutical Manufacture: State of the Art and Recent Trends (Jossen et al.) -- Chapter 2. Recent Developments in Bioprocess Monitoring Systems (Rahmatnejad et al.) -- Chapter 3. Advances in Characterization of Industrial Bioreactors for Cell Culture Process (Fitschen et al.) -- Chapter 4. Continuous Bioprocessing for Upstream Process - Perfusion Process (Chotteau et al.) -- Chapter 5. Continuous Bioprocessing for Downstream (Gerstweiler) -- Chapter 6. Towards Digital Twin for Biopharmaceutical Processes: Concept and Progress (Ding et al.) -- Chapter 7. Integrated Process and Supply Chain Design and Optimization (Triantafyllou et al.) -- Chapter 8. Production of Complex Proteins in Plants - From Farming to Manufacturing (Nausch et al.) -- Chapter 9. Manufacturing of Recombinant Proteins Using Quality by Design (QbD) Methodology: Current Trend and Challenges (Shin and Landauer) -- Chapter 10. Biopharma 4.0 for Biologics Manufacturing Under Pandemic Constraints (Schmidt et al.) -- Chapter 11. Biopharma 4.0: Digital Technologies Driving Smart Manufacturing (Nargund et al.) -- Part II: Manufacturing Aspects of Cell and Gene Therapy -- Chapter 12. Essential Aspects of Mesenchymal Stem Cell Manufacturing (Fleischhammer et al.) -- Chapter 13. Towards a Continuous Production of Human Mesenchymal Stromal Cells in a Chemically Defined Medium: Opportunities and Challenges for a Robust and Scalable Expansion Process (Tasto and Salzig) -- Chapter 14. Biomanufacturing Aspects of Gene Therapy (Warnock) -- Chapter 15. Manufacturing and Quality of Advanced Therapeutics: Cellular Therapies, CAR-T and Gene Therapies (van den Bos et al.)
520 $a This volume "Cell Engineerring 11 - Biopharmaceutical Manufacturing: Progress, Trends and Challenges" is a source of the latest innovative research and technical development in biomanufacturing systems. It is organised into 2 parts: 1) Manufacturing of recombinant therapeutic proteins (e.g. therapeutic antibodies, biosimilars/biogenerics) and 2) Manufacturing aspects of cell and gene therapy. Each with selected chapters on the following topics for both up- and downstream, such as: Advanced process strategies, especially continuous manufacturing, Advanced culture techniques, especially single-use systems, Process transfer, scale-up/scale-down models, Processing advances/Manufacturing productivity/efficiency, Model-assisted process understanding and development/Digital Twins, Process controls and analytics, Quality control, Quality by design, Facility design and full-scale commercial systems, manufacturing technology innovation. The book comprises contributions of experts from academia and industry active in the field of cell culture development for the production of recombinant proteins, cell therapy and gene therapy, with consideration of Digital Twin's and facility design. The knowledge and expertise of the authors cover disciplines like cell biology, engineering, biotechnology and biomedical sciences. Inevitably, some omissions will occur in the test, but the authors have sought to avoid duplications by extensive cross-referencing to chapters in other volumes of this series and elsewhere. We hope the volume provides a useful compendium of techniques for scientists in industrial and research laboratories active in this field.
650 0 $a Pharmaceutical biotechnology. $3 189023
650 0 $a Drug factories. $3 302738
650 1 4 $a Cell Biology. $3 274165
650 2 4 $a Biomedical Engineering and Bioengineering. $3 826326
650 2 4 $a Biotechnology. $3 188829
650 2 4 $a Bioprocess Engineering. $3 918932
650 2 4 $a Pharmaceutics. $3 913065
650 2 4 $a Biomaterials-Vaccines. $3 929055
700 1 $a Portner, Ralf. $3 339941
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Cell engineering ; $v v.9. $3 711691
856 4 0 $u https://doi.org/10.1007/978-3-031-45669-5
950 $a Biomedical and Life Sciences (SpringerNature-11642)